Life Sciences & Diagnostic Tools_2025 Emerging Growth Outlook_ Favor Applications vs Technologies
Applause·2025-01-15 07:04
ab 10 January 2025 Global Research Life Sciences & Diagnostic Tools 2025 Emerging Growth Outlook: Favor Applications vs Technologies Bottom Line Within our emerging growth coverage, we're more constructive on genomics application companies vs genomics technology companies in 2025. We've moved Guardant Health (GH) to our top pick within the group, with a view that the company has an underappreciated catalyst path, highlighted by ramp of its Shield test in CRC screening (see recent survey). Natera (NTRA) shou ...